has been cited by the following article(s):
|
[1]
|
Sphingosine kinase 2 regulates adipocyte browning and whole-body metabolism
Science Advances,
2026
DOI:10.1126/sciadv.aec7066
|
|
|
|
|
[2]
|
Subcutaneous administration of the sphingosine kinase 2 inhibitor ABC294640 has no metabolic benefits in high fat diet-induced obesity in male mice
Life Sciences,
2025
DOI:10.1016/j.lfs.2025.123952
|
|
|
|
|
[3]
|
Adipose Tissue
Contemporary Endocrinology,
2024
DOI:10.1007/978-3-031-72570-8_3
|
|
|
|
|
[4]
|
S1P/S1PR3 signalling axis protects against obesity-induced metabolic dysfunction
Adipocyte,
2022
DOI:10.1080/21623945.2021.2021700
|
|
|
|
|
[5]
|
Ceramide and sphingosine 1-phosphate in adipose dysfunction
Progress in Lipid Research,
2019
DOI:10.1016/j.plipres.2019.04.001
|
|
|
|
|
[6]
|
WITHDRAWN: Ceramide and Sphingosine 1-Phosphate in adipose dysfunction
Progress in Lipid Research,
2019
DOI:10.1016/j.plipres.2019.100991
|
|
|
|